Wilex AG (Wilex)

Oncology Corporate Profile

HQ Location

Grillparzerstr. 10
Munich, Germany 81675

Company Description

Wilex AG is a biopharmaceutical company based in Munich, Germany. Focused on oncology, the Company's portfolio includes diagnostic and therapeutic product candidates for the specific detection and targeted treatment of various types of cancer based on antibodies and small molecules. The WILEX subsidiary Heidelberg Pharma GmbH in Ladenburg, Germany, offers preclinical contract research services and an antibody drug conjugate (ADC) technology platform.

Website: http://www.wilex.de

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
RedectaneCAIX antibodyRenal cell carcinoma (RCC)III
RencarexCAIX antibodyRenal cell carcinoma (RCC)III
HDP-101-ATACantibody amanitin conjugateChronic Lymphocytic Leukemia (CLL)Preclinical
HDP-101-ATACantibody amanitin conjugateDiffuse Large B-Cell Lymphoma (DLBCL)Preclinical
HuMAB 5B1-ATACantibody amanitin conjugatePancreatic cancerPreclinical
PSMA-ATACantibody amanitin conjugateProstate cancerPreclinical
CD 19-ATACantibody amanitin conjugateVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://www.wilex.de

Recent News Headlines

There are no news items to display